Adapttech secures £2m in new funding to scale commercial operations and develop new medical technologies.
The biomedical startup has raised £2m from backers including Mercia and Bionova Capital.
Adapttech is a biomedical enterprise that creates wearable technologies to assist individuals with physical limitations. Its flagship offering combines 3D scanning with dynamic pressure data to streamline prosthetic fitting.
Adapttech has secured £2m in new funding from a consortium of venture capital firms and angel networks to drive commercial sales of its flagship prosthetic fitting system. The financing round was backed by existing investors alongside new participants, with the capital earmarked for product development and scaling operations. This milestone marks the firm's progression from development and clinical testing into full commercial deployment.
From the founder
"We’re delighted to have secured significant investment from both existing and new investors as we seek to drive sales of INSIGHT,"
Frederico Carpinteiro
CEO at Adapttech
Use of funds
- 01Continue product development
- 02Invest in sales and marketing
